Pricing Log in Create free account

OKYO Pharma Limited Sponsored ADR (OKYO) vs Tiziana Life Sciences Ltd (TLSA)

OKYO Pharma Limited Sponsored ADR and Tiziana Life Sciences Ltd are both Biotechnology companies. OKYO Pharma Limited Sponsored ADR and Tiziana Life Sciences Ltd are of similar size ($79.6M and $73.5M). Across the 5 metrics below, Tiziana Life Sciences Ltd leads on 3 and OKYO Pharma Limited Sponsored ADR on 2.

Valuation

Metric OKYO TLSA Biotechnology median
P/E n/m n/m 10.60
P/S n/m — 9.40
P/B 86.44 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.04 0.66
EV/Sales n/m n/m 9.02
Earnings yield 0.00% (74.83%) (32.88%)
Free cash flow yield (0.89%) 0.00% (23.13%)

Profitability

Metric OKYO TLSA Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin — — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 0.00% (51.96%)
Return on assets 0.00% 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric OKYO TLSA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (101.34%) (45.45%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric OKYO TLSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.43 0.76 4.97
Net debt to EBITDA 2.42 0.19 1.01

Dividend

Metric OKYO TLSA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric OKYO TLSA Biotechnology median
Market cap 73.47m 79.60m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack